/PHCUF
PHCUF Stock - Photocure ASA
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$5.58+0.00%
+$0.00 (+0.00%) • Dec 19
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.58
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.99
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $6.14
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PHCUF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$5.52 – $5.64
TARGET (TP)$6.42
STOP LOSS$5.13
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.53
52W High$6.00
52W Low$4.32
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $525.39M | $500.66M | $393.13M | $360.54M | $256.48M |
| Gross Profit | $494.67M | $474.52M | $370.44M | $336.49M | $237.97M |
| Gross Margin | 94.2% | 94.8% | 94.2% | 93.3% | 92.8% |
| Operating Income | $20.40M | $27.81M | $-49,003,000 | $9.39M | $-13,344,000 |
| Net Income | $-4,810,000 | $979,000 | $-71,857,000 | $-30,897,000 | $-22,403,000 |
| Net Margin | -0.9% | 0.2% | -18.3% | -8.6% | -8.7% |
| EPS | $-0.18 | $0.04 | $-2.66 | $-1.15 | $-0.91 |
Company Overview
Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PHCUFBeat Rate
11%
Last 9 quarters
Avg Surprise
-410.8%
EPS vs Estimate
Beats / Misses
1/8
Last 12 quarters
Latest EPS
$0.02
Q3 2025
EPS Surprise History
Q3 23
No data
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
-461.8%
$-0.13vs$-0.02
Q1 25
-1238.8%
$-0.21vs$0.02
Q2 25
-2081.3%
$-0.09vs$-0.00
Q3 25
+780.3%
$0.02vs$-0.00
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Feb 17, 2026 | — | — | — | — |
Q4 2025 | Oct 29, 2025 | $-0.01 | — | — | — |
Q3 2025 | Jul 30, 2025 | $-0.00 | $0.02 | +780.3% | ✓ BEAT |
Q2 2025 | May 8, 2025 | $-0.00 | $-0.09 | -2081.3% | ✗ MISS |
Q1 2025 | Feb 19, 2025 | $0.02 | $-0.21 | -1238.8% | ✗ MISS |
Q4 2024 | Nov 13, 2024 | $-0.02 | $-0.13 | -461.8% | ✗ MISS |
Q3 2024 | Aug 7, 2024 | — | $0.04 | — | — |
Q2 2024 | May 15, 2024 | — | $-0.03 | — | — |
Q1 2024 | Feb 21, 2024 | — | $0.05 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.02 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.01 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.04 | — | — |
Q1 2023 | Feb 23, 2023 | $-0.23 | $-0.79 | -243.5% | ✗ MISS |
Q4 2022 | Nov 2, 2022 | $-0.16 | $-0.37 | -131.3% | ✗ MISS |
Q3 2022 | Aug 10, 2022 | $-0.34 | $-0.68 | -100.0% | ✗ MISS |
Q2 2022 | May 11, 2022 | $-0.48 | $-0.82 | -70.8% | ✗ MISS |
Q1 2022 | Feb 23, 2022 | — | $-1.05 | — | — |
Q4 2021 | Nov 17, 2021 | $-0.04 | $-0.10 | -150.0% | ✗ MISS |
Q3 2021 | Aug 11, 2021 | — | $-0.40 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PHCUF
What is PHCUF's current stock price?
Photocure ASA (PHCUF) is currently trading at $5.58 per share. The stock has moved +0.00% today.
What is the analyst price target for PHCUF?
No analyst price targets are currently available for this stock.
What sector is Photocure ASA in?
Photocure ASA operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is PHCUF's market cap?
Photocure ASA has a market capitalization of $0.15 billion, making it a small-cap company.
Does PHCUF pay dividends?
No, Photocure ASA does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAAWH
Ascend Wellness Holdings, Inc.
$0.75
Mkt Cap: $0.2B
ACMLF
Ascom Holding AG
$4.37
Mkt Cap: $0.2B
BKUH
Bakhu Holdings, Corp.
$0.02
Mkt Cap: $0.0B
CBWTF
Auxly Cannabis Group Inc.
$0.11
Mkt Cap: $0.1B
HLTRF
HLS Therapeutics Inc.
$3.42
Mkt Cap: $0.1B
JUSHF
Jushi Holdings Inc.
$0.60
Mkt Cap: $0.1B
MLLCF
Molecular Partners AG
$3.50
Mkt Cap: $0.1B
ORXOY
Orexo AB (publ)
$2.60
Mkt Cap: $0.1B
WLDFF
Wildflower Brands Inc.
$0.00
Mkt Cap: $0.0B
YOURF
YourWay Cannabis Brands Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to PHCUF for comparison